✦ LIBER ✦

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Scribed by Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C. Dijkmans; Jürgen Braun; Maxime Dougados; John D. Reveille; Robert L. Wong; Hartmut Kupper; John C. Davis Jr.

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 143 KB
Volume: 54
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21913

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of golimumab in pati

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial

✍ Robert D. Inman; John C. Davis Jr.; Désirée Van Der Heijde; Laura Diekman; Joach 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 1 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score ≥4, and a back pain score of ≥4 were randomly assigned in a 1.8:1.8:1

Efficacy and safety of infliximab in pat

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)

✍ Désirée van der Heijde; Ben Dijkmans; Piet Geusens; Joachim Sieper; Kimberly DeW 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Clinical efficacy and safety of etanerce

Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double-blind trial

✍ Juergen Braun; Irene E. van der Horst-Bruinsma; Feng Huang; Ruben Burgos-Vargas; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 1 views

Efficacy and safety of milnacipran 100 m

Efficacy and safety of milnacipran 100 mg/day in patients with fibromyalgia: Results of a randomized, double-blind, placebo-controlled trial

✍ Lesley M. Arnold; R. Michael Gendreau; Robert H. Palmer; Judy F. Gendreau; Yong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

Adalimumab significantly reduces both sp

Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: A multicenter, randomized, double-blind, placebo-controlled study

✍ Robert G. W. Lambert; David Salonen; Proton Rahman; Robert D. Inman; Robert L. W 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 1 views

Six-month results of a double-blind, pla

Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis

✍ J. Brandt; A. Khariouzov; J. Listing; H. Haibel; H. Sörensen; L. Grassnickel; M. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

## Abstract ## Objective There is increasing evidence that tumor necrosis factor α (TNFα) is centrally involved in the pathogenesis of ankylosing spondylitis (AS) and other spondylarthritides. This study was designed to investigate the efficacy of anti‐TNFα therapy with etanercept, a 75‐kd recepto